# Pengyang

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pengyang

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.pengyangyiliao.com
- Total disclosed funding: $1.4M
- Latest round: Series B (Jan 12, 2024)
- Investors on record: 4

## About

Established in 2004 and based in Beijing, China, Pengyang is a technology company that focuses on the research and development of medical intelligent monitoring equipment. The company has obtained 6 national invention patents, 12 utility model patents, 26 computer software copyrights. It acquired certifications such as National Medical Products Administration and Conformite Europeenne. In January 2024, it closed a series B funding. 

The company's main products include 18-lead Holter monitoring system, wearable ambulatory blood pressure monitor and 18-lead Holter monitoring system. The 18-lead Holter Analysis System provides heart disease analysis and diagnosis services. The company's products are used in the field of cardiovascular disease.

The company will use the series B++ funding to accelerate the industrialization of the cardiovascular diagnostic service platform and to build a diagnostic service platform center.

## Funding rounds

- Series B, Jan 12, 2024, $1.4M — CCB International (Shenzhen) Asset Management
- Series A, Jul 24, 2018 — CCB International Asset Management, China Minsheng Investment Group, Kunshan Gaoxin Group

## Investors

- CCB International Asset Management (https://capitalatlas.ai/funds/ccb-international-asset-management) — Series A
- China Minsheng Investment Group (https://capitalatlas.ai/funds/china-minsheng-investment-group) — Series A
- Kunshan Gaoxin Group — Series A
- CCB International (Shenzhen) Asset Management (https://capitalatlas.ai/funds/ccb-international-shenzhen-asset-management) — Series B